1. Dana-Farber and Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA;
2. Biostatistics and Research Design Center, and;
3. Pediatric Hematology Oncology, Institutional Centers for Clinical and Translational Research, Boston Children’s Hospital, Boston, MA;
4. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;
5. Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH;
6. Department of Pediatrics, Hematology/Oncology, Baylor College of Medicine and Texas Children’s Hospital, Houston, TX;
7. Department of Pathology, Boston Children’s Hospital, Harvard Medical School, Boston, MA;
8. Department of Hematology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA;
9. Department of Pediatric Hematology, Seattle Children’s Hospital, Cancer and Blood Disorders Clinic, Seattle, WA;
10. Department of Pediatric Hematology, Oncology, and Bone Marrow Transplantation, Cleveland Clinic Children’s, Cleveland, OH;
11. Division of Hematology, University of Washington School of Medicine, Seattle, WA;
12. The Norris Cotton Cancer Center, Department of Pediatrics, Geisel School of Medicine at Dartmouth College, Lebanon, NH;
13. Division of Hematology Oncology and Stem Cell Transplantation, Cohen Medical Center, Zucker School of Medicine at Hofstra Northwell, New Hyde Park, NY;
14. Center for Cancer and Blood Disorders, Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, CO; and
15. Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN